A landmark study has confirmed that childbearing offers natural protection against breast cancer, with researchers identifying a specific type of immune cell as the likely mechanism. The findings from Australian scientists at the Peter MacCallum Cancer Centre could also shed light on the rising rates of breast cancer in women under 50.
The research, published in the journal Nature Immunology, indicates that women with higher levels of Killer T-cells in their breast tissue experience better outcomes. These specialized immune cells help detect and destroy abnormal cells, including cancer.
Professor Kara Britt, a co-lead author of the study, explained that these T-cells are recruited during pregnancy and can persist in breast tissue for years, actively patrolling for cancerous cells. "We uncovered that these T cells are recruited during pregnancy, but survive for a long time and potentially stay in the breast tissue patrolling it for abnormal cells for years," Britt stated. Protective cells were observed in breast tissue up to a decade after pregnancy.
These findings emerge amidst a significant increase in breast cancer diagnoses among younger populations. In the UK, approximately 8,500 young women are diagnosed with the disease annually. Experts have long suggested a link between earlier childbirth and reduced risk of ovarian and breast cancers, though they caution against creating undue anxiety for women who delay or cannot conceive.
The study revealed that pregnancy hormones stimulate the production of these killer T-cells in the breast around the midpoint of gestation. These cells continue to provide a long-term anti-tumor effect for up to 10 years after pregnancy, even after breastfeeding concludes.
Models suggest that T-cells located within milk ducts rely on milk-producing breast cells for survival. This dependency may explain why only women who experience a full-term pregnancy benefit from this protective effect.
Novel Prevention Avenues
Encouragingly, researchers were able to induce similar changes in breast cells using hormone treatments, triggering an influx of protective T-cells without the need for conception. "These findings are very exciting and open up new avenues for immune-preventative interventions that may reduce the development of breast cancer in high-risk populations who have not conceived," the research team concluded.
While the interplay between reproductive factors, hormones, and cancer risk is complex, other research supports the protective benefits of earlier childbearing. Breast cells are thought to remain immature and more vulnerable to hormones and abnormal growth until a woman becomes pregnant. Earlier pregnancy allows these cells to fulfill their natural function sooner, thereby reducing the window of opportunity for abnormal cell multiplication.
Dr. Andrea DeCensi, director of medical oncology at Galliera Hospital in Italy, suggests that the delay in childbearing is a significant contributor to the rise in breast cancer cases among those under 50. "Biologically, women are ready for pregnancy soon after their first period. The optimal window for childbearing is between 20 and 35. After that, not only does it become more difficult to conceive, but breast cancer risk significantly rises," DeCensi noted.
Studies indicate that women having their first child in their thirties are over 60% more likely to develop premenopausal breast cancer compared to those who give birth in their early twenties. The risk is also shown to decrease by up to 9% with each subsequent pregnancy.
Breastfeeding has also been linked to a reduced risk, potentially delaying the onset of the disease by ten years, provided it is maintained for over six months and the mother does not smoke.
Breast cancer is among 11 types of cancer showing an increase in young people, though a single cause has not been identified. It is currently the most common cancer in the UK, with over 59,000 new cases each year. Survival rates remain high, with approximately 77% of women living with the disease for ten years or more.